1977
DOI: 10.1016/s0140-6736(77)91011-x
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Postoperative Thromboembolism by Dextran 40, Low Doses of Heparin, or Xantinol Nicotinate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
2
4

Year Published

1977
1977
2005
2005

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 86 publications
(22 citation statements)
references
References 3 publications
0
16
2
4
Order By: Relevance
“…We intentionally started administration on the eve of operation since we are looking for prophylactic methods which are simple enough to be used in as many surgical patients as possi ble, including emergency surgery where thromboembolic complications are common. Dextran-70 did not reduce the incidence of deep-vein thrombosis in this study as much as in our previous trial with dextran-40 [6]. It is well known that dextran does not reduce the incidence of deep vein thrombosis as much as small doses of heparin when judged by the fi brinogen test [5,6,16].…”
Section: Discussioncontrasting
confidence: 42%
See 2 more Smart Citations
“…We intentionally started administration on the eve of operation since we are looking for prophylactic methods which are simple enough to be used in as many surgical patients as possi ble, including emergency surgery where thromboembolic complications are common. Dextran-70 did not reduce the incidence of deep-vein thrombosis in this study as much as in our previous trial with dextran-40 [6]. It is well known that dextran does not reduce the incidence of deep vein thrombosis as much as small doses of heparin when judged by the fi brinogen test [5,6,16].…”
Section: Discussioncontrasting
confidence: 42%
“…Dextran-70 did not reduce the incidence of deep-vein thrombosis in this study as much as in our previous trial with dextran-40 [6]. It is well known that dextran does not reduce the incidence of deep vein thrombosis as much as small doses of heparin when judged by the fi brinogen test [5,6,16]. In spite of this, dextran is apparently very effec tive in reducing the incidence of fatal pulmonary embolism [5,6,16].…”
Section: Discussioncontrasting
confidence: 41%
See 1 more Smart Citation
“…Thirteen trials [100][101][102][103][104][105][106][107][108][109][110][111][112] (1573 patients) assessed dextran as monotherapy, three trials 85,113,114 (420 patients) assessed dextran as adjunctive therapy (with heparin or an oral anticoagulant as background therapy) and two trials 61,115 (252 patients) assessed adding dextran to a mechanical compression method ( Figure 22).…”
Section: Dextran Effect Of Dextran On Dvtmentioning
confidence: 99%
“…The effect of dextran on PVT was reported in only six 101,104,106,107,112,114 of the 18 trials assessing dextran ( Figure 25). Overall, PVT occurred in 33 of 355 (9.3%) patients allocated to dextran versus 46 of 364 (12.6%) allocated control, corresponding to a reduction of 28% (21) in the odds of PVT (2p = NS).…”
Section: Effect Of Dextran On Proximal Venous Thrombosismentioning
confidence: 99%